Systematic Construction and Validation of a Metabolic Risk Model for Prognostic Prediction in Acute Myelogenous Leukemia

Background: Acute myelogenous leukemia (AML) is a heterogeneous disease with recurrent gene mutations and variations in disease-associated gene expression, which may be useful for prognostic prediction. Methods: RNA matrix and clinical data of AML were downloaded from GEO, TCGA, and TARGET databases...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yun, Hu, Fang, Li, Jin-yuan, Nie, Run-cong, Chen, Si-liang, Cai, Yan-yu, Shu, Ling-ling, Deng, De-jun, Xu, Jing-bo, Liang, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186449/
https://www.ncbi.nlm.nih.gov/pubmed/32373530
http://dx.doi.org/10.3389/fonc.2020.00540

Ejemplares similares

Ejemplares similares